3 terminated. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Terminated 3 |
Follow SARS-CoV 2: new trials by email Literature Review of SARS-CoV 2 trials Research Report on SARS-CoV 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) Nitric Oxide delivered via LungFit™ system - Corona Virus Infection, COVID-19 | Not applicable | Terminated | Beyond Air Inc. | 4 | 2020-06-13 | 2022-12-16 |
| Tannin Specific Natural Extract for COVID-19 Infection ARBOX, PLACEBO - COVID-19, SARS-CoV 2 | Not applicable | Terminated | Hospital de Clinicas José de San Martín | 124 | 2020-06-12 | 2020-12-22 |
| Exploring Brain Damages After COVID-19 Infection Auditory Evoked Potentials (AEP), Blink and Masseter Inhibitory Reflex - SARS-CoV 2 | Not applicable | Terminated | University Hospital, Bordeaux | 38 | 2020-05-19 | 2026-06-09 |
COVID-19 (3) · Coronavirus Infections (2) · Pneumonia, Viral (1) · Respiration Disorders (1) · Severe Acute Respiratory Syndrome (1) · Virus Diseases (1)
Coronaviridae Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Pneumonia, Viral (2) · Virus Diseases (2) · Coronavirus Infections (1)
Blinking (1) · Evoked Potentials, Auditory (1)
Beyond Air Inc. (1) · Hospital de Clinicas José de San Martín (1) · University Hospital, Bordeaux (1)
Argentina (1) · France (1) · United States (1)
Ashik Tal, MD (1) · Bertrand Glize (1) · Maria M Piskorz, MD (1)